| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |